Uncertainty in stock selection
Solution: Tailored portfolios of high-potential stocks eliminate guesswork and build conviction.
SEBI Registered · INH000014076
Vipin Dixena
Research Analyst
SEBI Registered Research Analyst · INH000014076
6+ years of market experience. Tailored equity portfolios for wealth creation — swing trading signals and long-term recommendations grounded in fundamental & quantitative research.
Proven approach to wealth creation
As a SEBI-registered Research Analyst, Vipin Dixena brings structured, research-backed investment strategy to retail investors seeking long-term wealth creation.
Whether you are a first-time investor or managing a sizable portfolio, the recommendations are data-driven, clearly reasoned, and built around your risk appetite.
6+
Years of market experience
2
Research services offered
SEBI
Registered RA · INH000014076
NISM
Certified research analyst
Solving the biggest investor frustrations
Real problems. Practical solutions built into every recommendation.
No time to monitor markets
Solution: Active, real-time monitoring — you get alerts when action is needed, nothing more.
Emotional decision-making
Solution: Data-driven strategies grounded in fundamentals, not news-cycle noise.
Overwhelming market information
Solution: Simplified, actionable insights cut through the noise and keep you focused.
Stock market research services
SEBI-compliant research recommendations for every investment horizon.
Short-term · Swing Trading
Swing Trading Recommendations
Actionable entry, exit, and stop-loss levels based on technical analysis. Designed for investors with a 5–30 day time horizon.
Get Started
Long-term · Wealth Creation
Build Wealth With Stocks
Fundamentally sound stock picks with a 1–3 year horizon. Portfolio-level thinking to help you build lasting wealth systematically.
Get Started
Risk Disclosure: Investment in securities market is subject to market risks. Read all related documents carefully before investing. Past performance is not indicative of future results. Registration granted by SEBI and certification from NISM do not guarantee performance of the intermediary or provide any assurance of returns to investors.
Built on expertise. Accountable to SEBI.
Every recommendation is research-backed, clearly documented, and compliant with SEBI RA regulations.
Actionable & Timely
Clear buy, sell, and rebalancing signals with defined price targets and rationale — no vague calls.
Comprehensive Coverage
From momentum trades to long-term compounders — both services designed to complement each other.
SEBI-Regulated
Operating under SEBI Registration INH000014076. Full compliance with the RA Master Circular 2024.
Risk Management First
Every recommendation includes a stop-loss level and position-sizing guidance so you never risk more than planned.
Featured on leading business channels
Recognised by ET Now, Financial Express and others for equity market expertise.
ET Now — MMTC Stock Analysis
ET Now — ITI Stock Strategy
Dixon Technologies Analysis
Market Insight
ET Now Panel Discussion
Stock Feature
News headlines
Stay ahead with in-depth coverage from leading business media.
Ready to build wealth systematically?
Share your details and we will reach out within 24 hours to understand your investment goals and recommend the right service.
- +91 82694 24108
- dixenavipin@gmail.com
- F-9, Mahamaya Plaza, Near Mundra Hospital, Mangla Road, Bilaspur, CG 495001
Send us a message
Your information is collected only to respond to your enquiry. See our Privacy Policy.
Investor Information & Compliance
As a SEBI-registered Research Analyst, all required disclosures are published below including annual audit status, complaint data in SEBI Annexure B format, escalation matrix, investor charter, and Dos & Don'ts.
Mandatory Notice (SEBI Circular SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024):
Clients are requested to go through Dos and Don'ts while dealing with a Research Analyst as specified in SEBI Master Circular or as may be specified by SEBI from time to time.
| Registered Name | VIPIN DIXENA |
|---|---|
| Registration Number | INH000014076 |
| Registration Type | Individual Research Analyst |
| SEBI Registration Date | As per SEBI records |
| NISM Certification | NISM-Series-XV: Research Analyst Certification |
| Validity | As per SEBI registration certificate |
| Registered Address | F-9, Mahamaya Plaza, Near Mundra Hospital, Mangla Road, Bilaspur, Chhattisgarh – 495001 |
| Contact Email | dixenavipin@gmail.com |
| Contact Phone | +91 82694 24108 |
As per SEBI (Research Analysts) Regulations, 2014, all registered Research Analysts are required to conduct an annual compliance audit. Audit status is disclosed as mandated.
Audit for Financial Year
2024–25
Audit Status
✓ Completed
Auditor Type
Independent Qualified Auditor
Audit Completion Date
29 September 2025
Non-Compliance Observations
✓ Fully Complied
Next Audit Due
2025–26 (by Sep 30, 2026)
Regulatory Reference: Annual audit is conducted as required under Regulation 19(3) of SEBI (Research Analysts) Regulations, 2014, and Clause 22 of the SEBI Master Circular for Research Analysts dated May 21, 2024.
Complaint data as mandated under SEBI Circular SEBI/HO/MIRSD-POD-1/P/CIR/2024/49 dated May 21, 2024 — Annexure B format.
Table 1 — Data for Month Ending August 2026
| S.No | Received From | Pending at End of Last Month | Received | Resolved | Total Pending | Pending > 3 Months | Avg Resolution Time (days) |
|---|---|---|---|---|---|---|---|
| 1 | Directly from Investors | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | SEBI (SCORES) | 0 | 0 | 0 | 0 | 0 | 0 |
| 3 | Other Sources | 0 | 0 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 | 0 | 0 |
Table 2 — Monthly Trend (Past 12 Months)
| S.No | Month | Carried Forward from Previous Month | Received | Resolved | Pending |
|---|---|---|---|---|---|
| 1 | September 2025 | 0 | 0 | 0 | 0 |
| 2 | October 2025 | 0 | 0 | 0 | 0 |
| 3 | November 2025 | 0 | 0 | 0 | 0 |
| 4 | December 2025 | 0 | 0 | 0 | 0 |
| 5 | January 2026 | 0 | 0 | 0 | 0 |
| 6 | February 2026 | 0 | 0 | 0 | 0 |
| 7 | March 2026 | 0 | 0 | 0 | 0 |
| 8 | April 2026 | 0 | 0 | 0 | 0 |
| 9 | May 2026 | 0 | 0 | 0 | 0 |
| 10 | June 2026 | 0 | 0 | 0 | 0 |
| 11 | July 2026 | 0 | 0 | 0 | 0 |
| 12 | August 2026 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 |
Table 3 — Annual Trend (Financial Years)
| S.No | Financial Year | Carried Forward | Received | Resolved | Pending |
|---|---|---|---|---|---|
| 1 | 2021–22 | 0 | 0 | 0 | 0 |
| 2 | 2022–23 | 0 | 0 | 0 | 0 |
| 3 | 2023–24 | 0 | 0 | 0 | 0 |
| 4 | 2024–25 | 0 | 0 | 0 | 0 |
| 5 | 2025–26 | 0 | 0 | 0 | 0 |
| Grand Total | 0 | 0 | 0 | 0 |
Source: RA internal records. SEBI SCORES complaints tracked separately at scores.sebi.gov.in.
In case of any grievance or complaint, please follow this escalation matrix:
1
Contact the Research Analyst directly
Email: dixenavipin@gmail.com |
Phone: +91 82694 24108
Expected response time: 3 working days.
2
SEBI SCORES — Online Complaint Portal
If not resolved within 30 days, register your complaint at SEBI SCORES:
scores.sebi.gov.in |
Toll free: 1800 266 7575 / 1800 22 7575
3
SMARTODR — Online Dispute Resolution
For securities market related disputes, you may also approach SMARTODR:
smartodr.in
Rights of Investors
- Receive research reports / recommendations with proper disclosures and rationale.
- Know the Research Analyst's SEBI registration details, qualifications, and disclosures.
- Receive services as agreed and described in the engagement terms.
- Lodge grievances and expect timely redressal per the escalation matrix above.
- Access SEBI SCORES and SMARTODR for unresolved grievances.
- Receive disclosures on conflicts of interest, if any, held by the RA or associates.
Responsibilities of Investors
- Read all research reports carefully before making any investment decision.
- Understand that research recommendations are for informational purposes only and not guaranteed returns.
- Verify SEBI registration of the Research Analyst before availing services.
- Pay fees only through official banking channels. Do not pay in cash.
- Report unregistered or fraudulent advisors to SEBI immediately.
- Do not share login credentials or personal financial information unnecessarily.
✓ Dos
- Always verify the RA's SEBI registration number before subscribing.
- Read the research report and understand the rationale before investing.
- Pay fees only via official digital payment channels with receipts.
- Keep records of all communications and recommendations received.
- Check SEBI SCORES for any past complaints against the RA.
- Assess your own risk appetite before following any recommendation.
✕ Don'ts
- Do not act on unverified tips shared via WhatsApp or social media claiming to be from any RA.
- Do not make cash payments for any research service.
- Do not share your trading account credentials with anyone.
- Do not invest based on guaranteed return promises — SEBI does not allow such claims.
- Do not ignore disclosures and risk warnings in research reports.
- Do not delay reporting fraud or malpractice to SEBI.
- The Research Analyst or his associates or his dependent family members may hold financial interest or actual/beneficial ownership in the financial products/securities recommended herein.
- The Research Analyst has not received any compensation from the company/companies mentioned in the research reports in the past 12 months.
- The Research Analyst does not serve as a director, officer, or employee of the subject company.
- The Research Analyst has not been engaged in market-making activities for the securities discussed.
- Research reports are for informational purposes only. They do not constitute an offer to buy or sell securities.